GE HealthCare wins $44M BARDA contract to develop AI-enabled ultrasound

BARDA sees challenges with using ultrasound in trauma care, leading it to task GE HealthCare with developing an automated 4D system and AI algorithms.

By Nick Paul Taylor • Oct. 13, 2023

European Commission orders Illumina to divest Grail

The order includes an undisclosed timeline and potential additional fines. Illumina, which has been anticipating the decision, maintains the commission does not have jurisdiction over the completed merger.

By Susan Kelly • Oct. 12, 2023

Explore the Trendline➔

New medical devices are reshaping the medtech industry

From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

By MedTech Dive staff

Top medtech conferences remaining in 2024

With several key conferences already wrapped, some of the biggest industry events left this year include the American Diabetes Association’s 84th Scientific Sessions and Advamed’s annual meeting.

By Susan Kelly • Updated June 3, 2024

J&J’s Abiomed hit with FDA warning letter over Impella heart pump

The letter identifies quality system problems in a group of recalled devices and says monitoring software used with the pump requires premarket authorization.

By Susan Kelly • Oct. 12, 2023

Boston Scientific wins diabetic neuropathy approval, joining rivals in growing market

The expanded indication positions Boston Scientific to challenge Abbott, Medtronic and Nevro for the emerging opportunity in spinal cord stimulation to treat the condition.

By Nick Paul Taylor • Oct. 12, 2023

Getinge inks $320M Healthmark takeover to bolster US sterile reprocessing capabilities

Buying Healthmark strengthens the position of Getinge in the U.S., building on two recent acquisitions of sterile reprocessing technology.

By Nick Paul Taylor • Oct. 12, 2023

How Medtronic, Zimmer Biomet and Smith & Nephew are thinking about acquisitions, spinoffs

Executives from the three medical device firms said they expect more deal-making in the long term, but face tough discussions about valuations with targets.

By Elise Reuter • Oct. 11, 2023

Haemonetics inks $253M OpSens buyout, adding cardiology guidewires to portfolio

The takeover will give Haemonetics devices that complement its vascular closure products, analysts said.

By Nick Paul Taylor • Oct. 11, 2023

5 financial challenges facing the medtech sector: EY

Declining stock prices, M&A, investment and revenues are dogging the industry in a difficult year, according to a new report from the consulting firm.

By Elise Reuter • Oct. 10, 2023

J&J-backed HistoSonics gets de novo clearance for liver cancer treatment

The system offers a minimally invasive alternative to surgical resection and thermal ablation in patients with primary and metastatic liver cancers.

By Nick Paul Taylor • Oct. 10, 2023

Clinicians ‘love yet fear’ AI, say medtech leaders

Stryker, Siemens Healthineers and Google execs said at the MedTech Conference that digital technology can help with patient care, but healthcare professionals also worry about it taking their jobs.

By Elise Reuter • Oct. 10, 2023

Insulet wins preliminary injunction against EOFlow in patent suit

A federal judge has blocked EOFlow, a company that Medtronic plans to acquire, from selling its insulin patch pump.

By Susan Kelly • Oct. 9, 2023

J&J could reach market-leading medtech growth after consumer spinoff: analysts

The analysts identified J&J’s leadership position in 11 categories, shift to fast-growing markets and investment in robotics as strengths.

By Nick Paul Taylor • Oct. 9, 2023

Best Buy to sell continuous glucose monitoring systems

It’s the tech retailer’s first foray into prescription-based medical device sales.

By Rebecca Pifer • Oct. 9, 2023

FDA says Philips’ testing of recalled devices is inadequate

The regulator called for further tests to evaluate health risks posed to patients from the sound abatement foam used in the devices.

By Elise Reuter • Oct. 6, 2023

GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership

GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.

By Elise Reuter • Oct. 6, 2023

Catheter ablation beats drugs in J&J retrospective study of AFib heart failure risk

Patients who received catheter ablation had a 57% lower risk of developing heart failure than their counterparts on antiarrhythmic drugs.

By Nick Paul Taylor • Oct. 6, 2023

Medtronic hires neuromodulation president from Smith+Nephew

Paolo Di Vincenzo will oversee strategy and operations for pain interventions and brain modulation.

By Susan Kelly • Oct. 5, 2023

Medtronic posts warning after stolen, defective intubation devices advertised for sale

The notice covers McGrath MAC video laryngoscopes that were designated for destruction and never released for sale.

By Nick Paul Taylor • Oct. 5, 2023

Akura Medical secures $35M to pursue FDA clearance for thrombectomy device

The money also will help fund clinical trials for additional indications and the expansion of its manufacturing capabilities.

By Susan Kelly • Oct. 4, 2023

Duke researchers find app improves autism screening in NIH-funded study

Participants who screened positive for autism had a nearly 41% probability of being diagnosed with the condition.

By Nick Paul Taylor • Oct. 4, 2023

Baxter hires new CFO from food industry

Joel Grade will join the company after 25 years at Sysco.

By Elise Reuter • Oct. 3, 2023

FDA expands total product life cycle program to cover neurological devices

The agency could enroll up to 45 additional devices over the coming year.

By Nick Paul Taylor • Oct. 3, 2023

FDA details switch to electronic filings for 510(k), de novo submissions

The guidance documents advance the transition to eSTAR, an electronic template the FDA is adopting to meet legislative requirements.

By Nick Paul Taylor • Oct. 3, 2023

Friend, not foe: How AI will revolutionize patient care

Artificial intelligence should be embraced to help streamline data and tackle clinician burnout, says Medtronic’s Stacey Churchwell.

By Stacey Churchwell • Oct. 2, 2023